Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
AstraZeneca
Express Scripts
Colorcon

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Claims for Patent: 6,201,105

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,201,105
Title: Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)
Abstract:Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
Inventor(s): Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA)
Assignee:
Application Number:09/233,461
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,201,105
Patent Claims:1. A recombinant protein comprising amino acids 1-163 of FIGS. 2A-2B, and wherein said recombinant protein binds TNF.

2. The recombinant protein of claim 1, wherein said protein comprises amino acids 1-185 of FIGS. 2A-2B.

3. The recombinant protein of claim 1, wherein said protein comprises amino acids 1-235 of FIGS. 2A-2C.

4. The recombinant protein of claim 1, wherein said extracellular region does not have native-pattern glycosylation.

Details for Patent 6,201,105

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Immunex Corporation ENBREL etanercept For Injection 103795 1998-11-02 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept For Injection 103795 1999-05-27 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept Injection 103795 2004-09-27 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept Injection 103795 2007-02-01 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL MINI etanercept Injection 103795 2017-09-14 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept Injection 103795 ⤷  Free Forever Trial 2009-09-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Mallinckrodt
Moodys
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.